Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 1 to 18 of 18

TitleReference numberPublishedLast updated
Fruquintinib for previously treated metastatic colorectal cancerTA1079
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA1065
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatmentsTA1008
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiencyTA914
Regorafenib for previously treated metastatic colorectal cancerTA866
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA716
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA709
Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancerTA668
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)TA240
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)TA334
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapyTA307
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapyTA242
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancerTA118
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancerTA212
Laparoscopic surgery for colorectal cancerTA105
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancerTA61

Results per page

  1. 10
  2. 25
  3. 50
  4. All